BUSINESSApr 27 · 00:19 UTCBLOOMBERGEyk Henning, Michelle F Davis, David Carnevali

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

Sun Pharma is set to acquire US-listed Organon in a $12 billion deal. The transaction marks a significant expansion for Sun Pharma in the pharmaceutical sector.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Sun PharmaorganizationOrganonorganizationPaul O'Driscollperson

Spot something wrong with this article?Report a problem →

Forward this